Zobrazeno 1 - 10
of 560
pro vyhledávání: '"Miguel A, Piris"'
Autor:
Victoria Menéndez, José L. Solórzano, Mónica García-Cosío, Ruth Alonso-Alonso, Marta Rodríguez, Laura Cereceda, Sara Fernández, Eva Díaz, Carlos Montalbán, Mónica Estévez, Miguel A. Piris, Juan F. García
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-14 (2024)
Abstract Classic Hodgkin lymphoma (cHL) is characterized by a rich immune microenvironment as the main tumor component. It involves a broad range of cell populations, which are largely unexplored, even though they are known to be essential for growth
Externí odkaz:
https://doaj.org/article/d92ac0978de049a99c9671f05201e407
Autor:
Christos Panayi, Ayse U. Akarca, Alan D. Ramsay, Ananth G. Shankar, Brunangelo Falini, Miguel A. Piris, David Linch, Teresa Marafioti
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
BackgroundThe clinicopathological spectrum of nodular lymphocyte predominant Hodgkin lymphoma (NLPHL), also known as nodular lymphocyte predominant B-cell lymphoma, partially overlaps with T-cell/histiocyte-rich large B-cell lymphoma (THRLCBL). NLPHL
Externí odkaz:
https://doaj.org/article/a9583936f525471a8aa038037f2ce241
Autor:
Marta Rodríguez, Ruth Alonso‐Alonso, Ismael Fernández‐Miranda, Rufino Mondéjar, Laura Cereceda, Álvaro Tráscasa, Anabel Antonio‐Da Conceiçao, Jennifer Borregón, Lucía Gato, Laura Tomás‐Roca, Carmen Bárcena, Begoña Iglesias, Fina Climent, Eva González‐Barca, Francisca Inmaculada Camacho, Émpar Mayordomo, Gabriel Olmedilla, Pilar Gómez‐Prieto, Yolanda Castro, Juana Serrano‐López, Joaquín Sánchez‐García, Santiago Montes‐Moreno, Mónica García‐Cosío, Paloma Martín‐Acosta, Juan F. García, María Planelles, Cristina Quero, Mariano Provencio, Ignacio Mahíllo‐Fernández, Socorro M. Rodríguez‐Pinilla, Enrico Derenzini, Stefano Pileri, Margarita Sánchez‐Beato, Raúl Córdoba, Miguel A. Piris
Publikováno v:
eJHaem, Vol 3, Iss 3, Pp 722-733 (2022)
Abstract Diffuse large B‐cell lymphoma (DLBCL), the most frequent non‐Hodgkin's lymphoma subtype, is characterized by strong biological, morphological, and clinical heterogeneity, but patients are treated with immunochemotherapy in a relatively h
Externí odkaz:
https://doaj.org/article/50ed2e5cc7ed44c6a502a8b55e0a336c
Autor:
Socorro María Rodríguez‐Pinilla, Rocío Nieves Salgado, Cristina Chamizo, Carlos Santonja, Peter Stewart, Nerea Carvajal, Neil McCafferty, Rebeca Manso, Daniel Morillo, Miguel Ángel Piris, David González de Castro
Publikováno v:
eJHaem, Vol 3, Iss 1, Pp 171-174 (2022)
Abstract We report a patient initially diagnosed with a triple hit high‐grade B cell lymphoma (HGBL‐TH), in which further morphologic, immunohistochemical, and next‐generation sequencing studies of subsequent specimens disclosed it to be a germ
Externí odkaz:
https://doaj.org/article/de817a459c354d80abfc309341a1a999
Autor:
Maher Albitar, Hong Zhang, Andre Goy, Zijun Y. Xu-Monette, Govind Bhagat, Carlo Visco, Alexandar Tzankov, Xiaosheng Fang, Feng Zhu, Karen Dybkaer, April Chiu, Wayne Tam, Youli Zu, Eric D. Hsi, Fredrick B. Hagemeister, Jooryung Huh, Maurilio Ponzoni, Andrés J. M. Ferreri, Michael B. Møller, Benjamin M. Parsons, J. Han van Krieken, Miguel A. Piris, Jane N. Winter, Yong Li, Bing Xu, Ken H. Young
Publikováno v:
Blood Cancer Journal, Vol 12, Iss 2, Pp 1-9 (2022)
Abstract Multiple studies have demonstrated that diffuse large B-cell lymphoma (DLBCL) can be divided into subgroups based on their biology; however, these biological subgroups overlap clinically. Using machine learning, we developed an approach to s
Externí odkaz:
https://doaj.org/article/93888a803eda4609ab485bda57596d9c
Autor:
Edwin U. Suárez, Javier Cornago, Miguel Á. Piris, Socorro M. Rodriguez Pinilla, José L. López‐Lorenzo, Carlos Soto
Publikováno v:
eJHaem, Vol 3, Iss 2, Pp 560-562 (2022)
Externí odkaz:
https://doaj.org/article/b9a7843b171349cba67d4c88b697f885
Autor:
Juan Carlos Caballero, Laura Pardo, Maria Socorro Rodriguez-Pinilla, Miguel Angel Piris, Beatriz Alvarez, Laura Solan, Javier Cornago, Jose Luis Lopez-Lorenzo, Pilar Llamas, Raul Cordoba, Alberto Lopez-Garcia
Publikováno v:
Medicina, Vol 59, Iss 6, p 1049 (2023)
Primary effusion lymphoma (PEL), Kaposi’s sarcoma (KS), and multicentric Castleman’s disease (MCD) is an uncommon group of diseases included in the same spectrum with related characteristics. The coexistence of all of them in the same individual
Externí odkaz:
https://doaj.org/article/ecd3a2c007464aee92b9647e1f5a42ac
Autor:
Laura Tomas-Roca, Marta Rodriguez, Ruth Alonso-Alonso, Socorro M. Rodriguez-Pinilla, Miguel Angel Piris
Publikováno v:
Hemato, Vol 2, Iss 2, Pp 281-304 (2021)
Diffuse large B-cell lymphomas (DLBCL)s, the most common type of Non-Hodgkin’s Lymphoma, constitute a heterogeneous group of disorders including different disease sites, strikingly diverse molecular features and a profound variability in the clinic
Externí odkaz:
https://doaj.org/article/196116d6496d4fe6956d6359126f38c2
Autor:
Juan Carlos Caballero, Elham Askari, Nerea Carrasco, Miguel Angel Piris, Begoña Perez de Camino, Laura Pardo, Javier Cornago, Jose Luis Lopez-Lorenzo, Pilar Llamas, Laura Solan
Publikováno v:
Biomedicines, Vol 11, Iss 4, p 1007 (2023)
Waldenström macroglobulinemia (WM) is a slowly progressive hematologic malignancy that usually responds rapidly to treatment. Being a lymphoplasmacytoid neoplasm, it is associated with a monoclonal IgM component, which may be associated with multipl
Externí odkaz:
https://doaj.org/article/aec131afc4a648ae875eb6a9c1fe91b6
Autor:
Miguel Górgolas Hernández-Mora, Alfonso Cabello Úbeda, Laura Prieto-Pérez, Felipe Villar Álvarez, Beatriz Álvarez Álvarez, María Jesús Rodríguez Nieto, Irene Carrillo Acosta, Itziar Fernández Ormaechea, Aws Waleed Mohammed Al-Hayani, Pilar Carballosa, Silvia Calpena Martínez, Farah Ezzine, Marina Castellanos González, Alba Naya, Marta López De Las Heras, Marcel José Rodríguez Guzmán, Ana Cordero Guijarro, Antonio Broncano Lavado, Alicia Macías Valcayo, Marta Martín García, Javier Bécares Martínez, Ricardo Fernández Roblas, Miguel Ángel Piris Pinilla, José Fortes Alen, Olga Sánchez Pernaute, Fredeswinda Romero Bueno, Sarah Heili-Frades, Germán Peces-Barba Romero
Publikováno v:
International Journal of Infectious Diseases, Vol 102, Iss , Pp 303-309 (2021)
Introduction: Tocilizumab (TCZ) is an interleukin-6 receptor antagonist, which has been used for the treatment of severe SARS-CoV-2 pneumonia (SSP), which aims to ameliorate the cytokine release syndrome (CRS) induced acute respiratory distress syndr
Externí odkaz:
https://doaj.org/article/2aae212706174c78b0f4443668f39cdb